Back to companies
Revolution Medicines, Inc.
RVMDUSNASDAQPharmaceuticals & HealthcareRevolution Medicines, Inc.
Revenue
—
FY2025
Operating income
-$1.2bn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API